Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Nov 6, 2023; 11(31): 7553-7561
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7553
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7553
Value of ultrasound and magnetic resonance imaging combined with tumor markers in the diagnosis of ovarian tumors
Qian Yang, Hui Zhang, Hai-Bao Wang, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui Province, China
Qian Yang, Taihe Hospital of Traditional Chinese Medicine, Fuyang 236000, Anhui Province, China
Pei-Qi Ma, Bin Peng, Fuyang People’s Hospital, Fuyang 236000, Anhui Province, China
Gui-Tao Yin, No. 2 People’s Hospital of Fuyang City, Fuyang 236000, Anhui Province, China
Nan-Nan Zhang, Linquan People’s Hospital, Fuyang 236000, Anhui Province, China
Author contributions: Yang Q and Zhang H contributed to the conceptualization of this study; Ma PQ, Peng B, Yin GT involved in the methodology of the manuscript; Zhang NN took part in the formal analysis; Wang HB contributed to the investigation; Yang Q prepared the original draft; Wang HB involved in the writing-review and editing, and supervision; and all authors have read and agreed to the published version of the manuscript.
Institutional review board statement: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the First Affiliated Hospital of Anhui Medical University.
Informed consent statement: The informed consent was obtained from all patients before specimen collection.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hai-Bao Wang, MD, PhD, Chief Physician, Professor, The First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Hefei 230022, Anhui Province, China. wang23415@126.com
Received: August 23, 2023
Peer-review started: August 23, 2023
First decision: September 13, 2023
Revised: September 21, 2023
Accepted: October 25, 2023
Article in press: October 25, 2023
Published online: November 6, 2023
Processing time: 74 Days and 23.6 Hours
Peer-review started: August 23, 2023
First decision: September 13, 2023
Revised: September 21, 2023
Accepted: October 25, 2023
Article in press: October 25, 2023
Published online: November 6, 2023
Processing time: 74 Days and 23.6 Hours
Core Tip
Core Tip: Ultrasound, magnetic resonance imaging, and tumor markers each have their own advantages and disadvantages when it comes to diagnosing ovarian tumors. However, by combining these three methods, we can significantly enhance the accuracy of ovarian tumor diagnosis, enabling early detection and identification of the tumor’s nature, and providing valuable guidance for clinical treatment.